Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus
UMass Medical School’s research achievements in virology, immunology, host response, drug design and advanced therapeutics support an accelerated approach to crucial new research projects aimed at COVID-19 and the virus that causes it, SARS-CoV-2.
Investigators listed here are using expertise and insight developed while working on understanding and treating some of the world’s most challenging diseases. Successful research programs at UMass Medical School have developed vaccines or antiviral drugs for viruses such as HIV, Ebola, influenza and RSV; other UMMS labs are world leaders in the design and testing of new approaches to therapeutics, which they are now applying to SARS-CoV-2.
Current and upcoming clinical trials include:
Learn more about the researchers involved in clinical trials
For more information on clinical trials, visit the Conquering Diseases
website.
In their efforts to prevent new cases of COVID-19, researchers are:
Learn more about the researchers involved in diagnostics
and vaccine development
In their efforts toward developing treatments for COVID-19, researchers are working to:
In exploration of host response to SARS-CoV-2, researchers are:
As many as four in 10 adults would refuse or hesitate to get a COVID-19 vaccine, according to a national survey, results of which were published in the Annals of Internal Medicine. Study co-authors Kimberly Fisher, MD, and Kathleen Mazor, EdD, say the findings indicate that health education outreach would be necessary to achieve widespread uptake of a safe and effective vaccine.
Read more